131 related articles for article (PubMed ID: 2053504)
1. Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients.
Knockaert DC; Dejaeger E; Nestor L; Verbist L; Pelemans W
Age Ageing; 1991 Mar; 20(2):135-9. PubMed ID: 2053504
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of aztreonam in a psychogeriatric population.
Roelandts F
Acta Clin Belg; 1992; 47(4):251-5. PubMed ID: 1329413
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
McKellar PP
Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
5. Empiric antibiotic use--aztreonam as a model.
Levin S
Am J Med; 1990 Mar; 88(3C):21S-23S; discussion 38S-42S. PubMed ID: 2316555
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.
Heney D; Lewis IJ; Ghoneim AT; Chisholm P; Bailey CC
J Antimicrob Chemother; 1991 Jul; 28(1):117-29. PubMed ID: 1769930
[TBL] [Abstract][Full Text] [Related]
7. Flucloxacillin-induced hypokalaemia: a case report.
De Backer E; Hannon H
Acta Clin Belg; 2018 Dec; 73(6):435-438. PubMed ID: 29447079
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
Tsuda S; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Horiike S; Taniwaki M; Misawa S; Inazawa J; Abe T
Jpn J Antibiot; 1989 Sep; 42(9):1926-37. PubMed ID: 2810755
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
Clergeot A; Steru D; Rosset MA; Carbon C
J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
[TBL] [Abstract][Full Text] [Related]
12. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
13. The use of aztreonam in serious gram-negative infections.
Smith G; Bunney RG; Farrell ID; Wood MJ
J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
[TBL] [Abstract][Full Text] [Related]
14. [Fundamental and clinical studies on aztreonam in the gynecological field].
Hanada S; Ikeuchi M; Oshima T; Nakaya T; Yagami Y; Yamada Y; Hayashi Y; Takagi T; Ishimaru T; Kitamura T
Jpn J Antibiot; 1985 Dec; 38(12):3609-18. PubMed ID: 3834146
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
16. The clinical use of aztreonam.
Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
18. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on aztreonam following intravenous drip infusion].
Yoshimoto M; Nakanishi Y; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Shimizu K; Ueda N
Jpn J Antibiot; 1985 Oct; 38(10):2827-37. PubMed ID: 4078996
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
